Market Place
Sourcing Support
Biostem Appoints Katherine Gorrell Chief Legal & Compliance
30 Apr 2026 //
GLOBENEWSWIRE
Biostem Technologies To Host Q1 2026 Financial Results
30 Apr 2026 //
GLOBENEWSWIRE
BioStem Presents Innovations at SAWC Conference
08 Apr 2026 //
GLOBENEWSWIRE
BioStem Technologies to Present at Needham Healthcare Conference
31 Mar 2026 //
GLOBENEWSWIRE
BioStem Technologies Releases Audited 2024 Financials
30 Mar 2026 //
GLOBENEWSWIRE
Biostem Tech Reveals 2025 Financial Results
24 Mar 2026 //
GLOBENEWSWIRE
Biostem Appoints Jodi Ungrodt As Audit Committee Chair
23 Mar 2026 //
GLOBENEWSWIRE
BioStem Technologies Hosts Q4, FY 2025 Results Call March 24
11 Mar 2026 //
GLOBENEWSWIRE
BioTissue Holding Sells Surgical, Wound Care Business To Biostem
21 Jan 2026 //
PR NEWSWIRE
BioStem Technologies Acquires Biotissue Holdings` Wound Care
21 Jan 2026 //
GLOBENEWSWIRE
BioStem Comments on CMS`s CY 2026 Rule Withdrawal
07 Jan 2026 //
GLOBENEWSWIRE
BioStem Products Placed on “12-Month Status Quo Period” List
18 Dec 2025 //
GLOBENEWSWIRE
Biostem Technologies Expands Product Access In Medicaid
25 Nov 2025 //
GLOBENEWSWIRE
Biostem Tech Files Restated Financial Statements
13 Nov 2025 //
GLOBENEWSWIRE
Biostem Technologies Reports Third Quarter 2025 Financial Results
13 Nov 2025 //
GLOBENEWSWIRE
BioStem Technologies Secures HQ at FAU Research Park
05 Nov 2025 //
GLOBENEWSWIRE
Biostem Technologies Comments On CMS Medicare Reimbursement Rule
05 Nov 2025 //
GLOBENEWSWIRE
Biostem Technologies To Host Q3 2025 Financial Results
30 Oct 2025 //
GLOBENEWSWIRE
Biostem Appoints KPMG As Independent Public Accountant
27 Oct 2025 //
GLOBENEWSWIRE
Biostem Expands Partnership With Florida Panthers For `Heroes
02 Oct 2025 //
GLOBENEWSWIRE
BioStem to Present at Two Upcoming Investor Conferences
02 Sep 2025 //
GLOBENEWSWIRE
BioStem Tech Insider Share Purchase by Chairman and CEO
21 Aug 2025 //
GLOBENEWSWIRE
Brandon Poe Named Cfo at Bio Stem Technologies
14 Aug 2025 //
GLOBENEWSWIRE
Bio Stem Technologies Reports Q2 2025 Financial Results
14 Aug 2025 //
GLOBENEWSWIRE
BioStem Technologies` Q2 2025 Financial Results on August 14
30 Jul 2025 //
GLOBENEWSWIRE
BioStem Comments on 2026 CMS Rule for Skin Products
17 Jul 2025 //
GLOBENEWSWIRE
BioStem Technologies to Present at Advanced Wound Care Summit
10 Jul 2025 //
GLOBENEWSWIRE
BioStem Technologies Enrolls in Trial for Diabetic Foot Ulcers
23 Jun 2025 //
GLOBENEWSWIRE
BioStem Technologies at Goldman Sachs 46th Annual Healthcare Conf
29 May 2025 //
GLOBENEWSWIRE
BioStem Technologies Reports Q1 2025 Results
12 May 2025 //
GLOBENEWSWIRE
BioStem to Showcase BioREtain® Technology at SAWC Spring Meeting
01 May 2025 //
GLOBENEWSWIRE
BioStem Technologies to Host Q1 2025 Financial Results Call
30 Apr 2025 //
GLOBENEWSWIRE
BioStem Technologies to Present at the Centri Capital Conference
21 Apr 2025 //
GLOBENEWSWIRE
BioStem Tech Reports Record Q4 Net Revenue of $102.9M
14 Apr 2025 //
GLOBENEWSWIRE
BioStem Technologies to Host Q4 & Full Year 2024 Financial Result
08 Apr 2025 //
GLOBENEWSWIRE
BioStem Technologies Extends 2024 Annual Report Filing with OTC
01 Apr 2025 //
GLOBENEWSWIRE
BioStem Receives Notice of Allowance for Two U.S. Patents
31 Mar 2025 //
GLOBENEWSWIRE
BioStem Tech To Present At Needham Virtual Conference
27 Mar 2025 //
GLOBENEWSWIRE
Biostem Reports $102.9M Q4 Revenue, Full-Year Reaches $301.8M
13 Jan 2025 //
GLOBENEWSWIRE
BioStem Launches Trial For BioREtain In Treating Foot Ulcers
08 Jan 2025 //
GLOBENEWSWIRE
BioStem Announces U.S. Patent Allowance for Placental Allografts
25 Nov 2024 //
GLOBENEWSWIRE
BioStem Technologies Signs LOI To Acquire Wound Care Products
20 Nov 2024 //
GLOBENEWSWIRE
BioStem Technologies Reports Q3 2024 Revenue of $82.6 Million
12 Nov 2024 //
GLOBENEWSWIRE
BioStem Technologies Reports Q3 2024 Financial Results Nov. 12
28 Oct 2024 //
#N/A
BioStem Technologies Files Form 10 & Submits Nasdaq Uplisting
30 Sep 2024 //
GLOBENEWSWIRE
BioStem to Present at H.C. Wainwright Conference in New York on September 9
29 Aug 2024 //
GLOBENEWSWIRE
BioStem Technologies Reports Record Second Quarter 2024 Revenue of $74.5 Million
12 Aug 2024 //
GLOBENEWSWIRE
BioStem Technologies To Report Q2 2024 Results On August 12
05 Aug 2024 //
GLOBENEWSWIRE
BioStem Gets IRB Approval For AmnioWrap2 Diabetic Foot Ulcer Study
10 Jul 2024 //
GLOBENEWSWIRE
BioStem Reports Breakthrough Results with AmnioWrap2 in Wound Care Study
26 Jun 2024 //
GLOBENEWSWIRE
BioStem Technologies to Sponsor MRO Better Half Dash
29 May 2024 //
GLOBENEWSWIRE
BioStem Technologies Reports Record First Quarter Revenue of $41.9 Million
14 May 2024 //
GLOBENEWSWIRE
BioStem To Report Q1 2024 Financial Results On May 14
07 May 2024 //
GLOBENEWSWIRE
BioStem Technologies Granted Prioritized Examination for Wound Healing Patent
06 May 2024 //
GLOBENEWSWIRE
BioStem Hires McCoy To Lead DFU, VLU Trials For BioREtain Allografts
30 Apr 2024 //
GLOBENEWSWIRE
BioStem Technologies to Present at the 2024 Planet MicroCap Showcase
25 Apr 2024 //
GLOBENEWSWIRE
BioStem Completes Audit, Prepares for Uplisting
24 Apr 2024 //
GLOBENEWSWIRE
BioStem to Present at the 14th Annual LD Micro Invitational Conference
02 Apr 2024 //
GLOBENEWSWIRE
BioStem Reports Fourth Quarter Revenue of $11.5 Million, 14-Fold YoY Increase
01 Apr 2024 //
GLOBENEWSWIRE
BioStem to Report Q4 FY23 on Monday, April 01, 2024
21 Mar 2024 //
GLOBENEWSWIRE
